Indeed, although NMO is a demyelinating disease of the CNS that shares several clinical features with MS, autoantibodies to aquaporin-4 are diagnostic of the disease and have been identified as a key pathogenic mediator of CNS damage (20), mechanistically setting it apart from MS. This evidence concerns the gene AQP4 and myeloid sarcoma.